Back to search
FDAFDA · Food and drugs·Recall number D-0594-2026

Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03.

Published June 24, 2026 · Recall initiated: May 27, 2026

Summary

FDA records drug Class II recall D-0594-2026, published June 24, 2026 and initiated May 27, 2026. Recalling firm: Ajanta Pharma USA Inc; Status: Ongoing; Reported quantity: 6,143 bottles; Lot: Lot: PA00805, expires: 01/31/2029. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

What to do

Voluntary: Firm initiated · Letter

Get an email if ARIPIPRAZOLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ARIPIPRAZOLE
Manufacturer
Ajanta Pharma USA Inc
Distributor
U.S. Nationwide
UPC
0327241051036
Lot
Lot: PA00805, expires: 01/31/2029
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-056-03. recalled?

Yes. FDA published recall D-0594-2026 on June 24, 2026. Reported hazard: Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ARIPIPRAZOLE. UPC: 0327241051036.